|Share this content:|
|Home||About Us||Our Attorneys||Cases||Practice Areas||Settlement Notices||News & Events||Contact Us|
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Uroplasty, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Uroplasty, Inc. (“Uroplasty” or the “Company”) (NASDAQ: UPI).
The investigation focuses on whether the Company and its executives violated federal securities laws with respect to its disclosures concerning business, operational, and compliance policies. Specifically, the investigation focuses on whether Uroplasty failed to disclose that it improperly recognized revenues and that it made improper payments of commission sales.
On June 14, 2013, the Company announced that it would delay filing its Annual Report for the year ended March 31, 2013, pending a review of its internal control regarding financial reporting. It further stated that its Chief Financial Officer would be placed on administrative leave. Following this news, Uroplasty’s stock price dropped over 10%.
If you invested in Uroplasty’s stock or options between July 26, 2012 and June 13, 2013 and would like to discuss your legal rights, you can contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to firstname.lastname@example.org or email@example.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Uroplasty’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Please tell us about yourself by completing the form and we will provide you with additional
information on how to join the Class Action at no cost to you. If you want to be a Lead Plaintiff or join
this action now, please click HERE.